title: Metastatic prostate cancer in 2015: The new and the old that is new again.
authors.affiliation: Oregon Health &Science University Knight Cancer Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA.
authors.forename: Julie N
authors.initials: JN
authors.lastname: Graff
authors.affiliation: Oregon Health &Science University Knight Cancer Center, 3710 SW US Veterans Hospital Road, Portland, Oregon 97239, USA.
authors.forename: Tomasz M
authors.initials: TM
authors.lastname: Beer
mesh_terms: D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000077143:Docetaxel; D006801:Humans; D008297:Male; D058990:Molecular Targeted Therapy / Q000639:trends; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy / Q000235:genetics / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000008:administration & dosage*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D043823:Taxoids; D000077143:Docetaxel